MX2019008564A - Composiciones inmunogenicas para su uso en vacunas neumococicas. - Google Patents
Composiciones inmunogenicas para su uso en vacunas neumococicas.Info
- Publication number
- MX2019008564A MX2019008564A MX2019008564A MX2019008564A MX2019008564A MX 2019008564 A MX2019008564 A MX 2019008564A MX 2019008564 A MX2019008564 A MX 2019008564A MX 2019008564 A MX2019008564 A MX 2019008564A MX 2019008564 A MX2019008564 A MX 2019008564A
- Authority
- MX
- Mexico
- Prior art keywords
- immunogenic compositions
- pneumococcal vaccines
- pneumococcal
- present
- pneumoniae
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 229960001973 pneumococcal vaccines Drugs 0.000 title abstract 2
- 208000035109 Pneumococcal Infections Diseases 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Un objeto de la presente invención es proporcionar composiciones inmunogénicas para protección contra S.pneumoniae, en particular contra El grupo sérico 18 de S. pneumoniae, mientras que limita el número de conjugados. La presente invención por lo tanto se relaciona con composiciones inmunogénicas novedosas para su uso en vacunas neumocócicas y en vacunación de sujetos humanos, en particular lactantes y personas mayores, contra infecciones neumocócicas utilizando las composiciones inmunogénicas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762448485P | 2017-01-20 | 2017-01-20 | |
| PCT/IB2018/050084 WO2018134693A1 (en) | 2017-01-20 | 2018-01-05 | Immunogenic compositions for use in pneumococcal vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019008564A true MX2019008564A (es) | 2019-09-19 |
| MX392525B MX392525B (es) | 2025-03-12 |
Family
ID=61028107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019008564A MX392525B (es) | 2017-01-20 | 2018-01-05 | Composiciones inmunogenicas para su uso en vacunas neumococicas |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11413344B2 (es) |
| EP (1) | EP3570879B1 (es) |
| JP (1) | JP7120767B2 (es) |
| KR (1) | KR102459629B1 (es) |
| CN (1) | CN110198735A (es) |
| AU (1) | AU2018208844B2 (es) |
| BR (1) | BR112019014833A2 (es) |
| DK (1) | DK3570879T3 (es) |
| ES (1) | ES2911490T3 (es) |
| HR (1) | HRP20220573T1 (es) |
| HU (1) | HUE059252T2 (es) |
| IL (1) | IL268168A (es) |
| MX (1) | MX392525B (es) |
| PL (1) | PL3570879T3 (es) |
| RU (1) | RU2762723C2 (es) |
| SI (1) | SI3570879T1 (es) |
| WO (1) | WO2018134693A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2710393C2 (ru) * | 2014-01-21 | 2019-12-26 | Пфайзер Инк. | Способ получения иммуногенного конъюгата капсульный полисахарид Streptococcus pneumoniae-белок-носитель |
| TWI756893B (zh) * | 2015-07-21 | 2022-03-01 | 美商輝瑞股份有限公司 | 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途 |
| EP3558363A1 (en) | 2016-12-21 | 2019-10-30 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| AU2018208844B2 (en) | 2017-01-20 | 2021-02-25 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| KR20190108583A (ko) | 2017-01-31 | 2019-09-24 | 머크 샤프 앤드 돔 코포레이션 | 다당류-단백질 접합체 제조 방법 |
| CA3050120A1 (en) | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| CN111093649B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| CN111065387B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| US11116828B2 (en) | 2017-12-06 | 2021-09-14 | Merck Sharp & Dohme Corp. | Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| US20210252125A1 (en) | 2018-04-30 | 2021-08-19 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| US11896656B2 (en) | 2018-04-30 | 2024-02-13 | Merck Sharp & Dohme Llc | Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide |
| WO2019212842A1 (en) | 2018-04-30 | 2019-11-07 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| BR112021011961A8 (pt) | 2018-12-19 | 2023-02-07 | Merck Sharp & Dohme | Composições compreendendo conjugados de polissacarídeo-proteína de streptococcus pneumoniae e métodos de uso dos mesmos |
| CN116322779A (zh) | 2020-09-10 | 2023-06-23 | 联合免疫股份有限公司 | 复合体 |
| WO2022101745A2 (en) | 2020-11-10 | 2022-05-19 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2024241172A2 (en) | 2023-05-19 | 2024-11-28 | Glaxosmithkline Biologicals Sa | Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4709017A (en) | 1985-06-07 | 1987-11-24 | President And Fellows Of Harvard College | Modified toxic vaccines |
| US4950740A (en) | 1987-03-17 | 1990-08-21 | Cetus Corporation | Recombinant diphtheria vaccines |
| GB8815795D0 (en) | 1988-07-02 | 1988-08-10 | Bkl Extrusions Ltd | Glazing bead |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
| ES2055785T3 (es) | 1989-01-17 | 1994-09-01 | Eniricerche Spa | Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas. |
| FI920131A0 (fi) | 1989-07-14 | 1992-01-13 | Praxis Biolog Inc | Cytokin- och hormonbaerare foer konjugatvaccin. |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| DE69113564T2 (de) | 1990-08-13 | 1996-05-30 | American Cyanamid Co | Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff. |
| EP1958646A1 (en) | 1992-02-11 | 2008-08-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| EP0643559B1 (en) | 1992-05-06 | 1999-04-14 | The President And Fellows Of Harvard College | Diphtheria toxin receptor-binding region |
| EP0671948B1 (en) | 1992-06-25 | 1997-08-13 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
| IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
| ES2231770T3 (es) | 1993-03-05 | 2005-05-16 | Wyeth Holdings Corporation | Nuevos plasmidos para la produccion de proteina crm y toxina difterica. |
| ES2109685T5 (es) | 1993-03-23 | 2005-09-01 | Smithkline Beecham Biologicals S.A. | Composiciones para vacunas que contienen monofosforil-lipido a 3-o-desacilado. |
| NZ274376A (en) | 1993-09-22 | 1997-11-24 | Jackson H M Found Military Med | Activating soluble carbohydrate using cyanylating reagents for the production of immunogenic constructs |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US5917017A (en) | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
| US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| CA2560114A1 (en) | 1994-07-15 | 1996-02-01 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| ES2200059T3 (es) | 1995-03-22 | 2004-03-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Produccion de construcciones inmunogenicas usando carbohidratos solubles activados mediante reactivos cianilados organicos. |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| AUPO517897A0 (en) | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
| EP1039935A4 (en) | 1997-02-28 | 2005-04-27 | Univ Iowa Res Found | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| ATE370740T1 (de) | 1997-05-20 | 2007-09-15 | Ottawa Health Research Inst | Verfahren zur herstellung von nukleinsäurekonstrukten |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| DE69838992T2 (de) | 1997-09-05 | 2008-12-24 | Glaxosmithkline Biologicals S.A., Rixensart | Öl-in-Wasser Emulsionen mit Saponinen |
| US6303114B1 (en) | 1998-03-05 | 2001-10-16 | The Medical College Of Ohio | IL-12 enhancement of immune responses to T-independent antigens |
| CA2323929C (en) | 1998-04-03 | 2004-03-09 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| WO1999052549A1 (en) | 1998-04-09 | 1999-10-21 | Smithkline Beecham Biologicals S.A. | Adjuvant compositions |
| GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
| DK1126876T3 (da) | 1998-10-16 | 2007-07-02 | Glaxosmithkline Biolog Sa | Adjuvanssystemer og vacciner |
| PT1140157E (pt) | 1998-12-21 | 2009-05-06 | Medimmune Inc | Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas |
| PT2261358E (pt) | 1998-12-23 | 2014-07-30 | Id Biomedical Corp Quebec | Antigénios de streptococcus |
| AUPP807399A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
| EP2204186B1 (en) | 1999-02-17 | 2016-04-06 | CSL Limited | Immunogenic complexes and methods relating thereto |
| IL145043A0 (en) | 1999-03-19 | 2002-06-30 | Smithkline Beecham Biolog | Vaccine |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| JP2002541808A (ja) | 1999-04-09 | 2002-12-10 | テクラブ, インコーポレイテッド | ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア |
| TR200103018T2 (tr) | 1999-04-19 | 2002-02-21 | Beecham Biologicals S.A. Smithkline | İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri. |
| EP1221971A2 (en) | 1999-09-24 | 2002-07-17 | SmithKline Beecham Biologics SA | Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| CA2383110A1 (en) | 1999-09-24 | 2001-03-29 | Veronique Henderickx | Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant |
| GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
| EA006232B1 (ru) | 2000-06-20 | 2005-10-27 | Ай Ди Биомедикал Корпорейшн | Стрептококковые антигены |
| US20030035806A1 (en) | 2001-05-11 | 2003-02-20 | D'ambra Anello J. | Novel meningitis conjugate vaccine |
| CA2492823A1 (en) | 2001-09-14 | 2003-03-27 | Martin F. Bachmann | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
| US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
| JP4597123B2 (ja) | 2003-03-13 | 2010-12-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 細菌性細胞溶解素の精製方法 |
| CA2519511A1 (en) | 2003-03-17 | 2004-09-30 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| AU2005333126A1 (en) | 2004-07-18 | 2006-12-21 | Csl Limited | Methods and compositions for inducing innate immune responses |
| EP1781325A2 (en) | 2004-07-18 | 2007-05-09 | CSL Limited | Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| GB0421083D0 (en) | 2004-09-22 | 2004-10-27 | Glaxosmithkline Biolog Sa | Purification process |
| US7718791B2 (en) | 2005-04-08 | 2010-05-18 | Wyeth Llc | Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation |
| CN102716480B (zh) | 2005-04-08 | 2023-03-21 | 惠氏有限责任公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物 |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| GB0607088D0 (en) * | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| DK2384765T3 (en) * | 2005-12-22 | 2017-01-09 | Glaxosmithkline Biologicals Sa | Vaccine against Streptococcus pneumoniae. |
| MX2009003730A (es) | 2006-10-10 | 2009-04-22 | Wyeth Corp | Purificacion de polisacaridos de streptococcus pneumoniae tipo 3. |
| SI2436700T1 (sl) | 2007-03-23 | 2018-09-28 | Wyeth Llc | Skrajšan postopek čiščenja za proizvodnjo kapsularnih polisaharidov streptococcusa pneumoniae |
| PL2167121T3 (pl) | 2007-06-26 | 2016-01-29 | Glaxosmithkline Biologicals Sa | Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae |
| NZ595291A (en) | 2009-03-24 | 2013-08-30 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| WO2010125480A1 (en) | 2009-04-30 | 2010-11-04 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
| SG10201403702SA (en) | 2009-06-29 | 2014-09-26 | Genocea Biosciences Inc | Vaccines and compositions against streptococcus pneumoniae |
| CN102068690A (zh) * | 2010-12-31 | 2011-05-25 | 北京民海生物科技有限公司 | 多价肺炎球菌荚膜多糖结合疫苗及其制备方法 |
| CA2881420C (en) | 2012-08-16 | 2016-11-15 | Pfizer Inc. | Glycoconjugation processes and compositions |
| FI3363806T3 (fi) | 2012-12-20 | 2023-01-31 | Glykokonjugaatiomenetelmä | |
| CN103495161B (zh) | 2013-10-08 | 2019-06-18 | 江苏康泰生物医学技术有限公司 | 一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法 |
| US20160324949A1 (en) * | 2014-01-21 | 2016-11-10 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
| NZ721943A (en) * | 2014-01-21 | 2022-07-01 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| CN104069504B (zh) | 2014-05-11 | 2019-09-24 | 江苏康泰生物医学技术有限公司 | 一种增强多糖蛋白结合物免疫原性的方法 |
| IL252915B2 (en) | 2015-01-15 | 2024-04-01 | Pfizer | Immunogenic compositions for use in pneumococcal vaccines |
| AU2018208844B2 (en) | 2017-01-20 | 2021-02-25 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
-
2018
- 2018-01-05 AU AU2018208844A patent/AU2018208844B2/en not_active Ceased
- 2018-01-05 PL PL18701573T patent/PL3570879T3/pl unknown
- 2018-01-05 KR KR1020197020691A patent/KR102459629B1/ko active Active
- 2018-01-05 EP EP18701573.0A patent/EP3570879B1/en active Active
- 2018-01-05 RU RU2019122619A patent/RU2762723C2/ru active
- 2018-01-05 HU HUE18701573A patent/HUE059252T2/hu unknown
- 2018-01-05 HR HRP20220573TT patent/HRP20220573T1/hr unknown
- 2018-01-05 BR BR112019014833A patent/BR112019014833A2/pt not_active IP Right Cessation
- 2018-01-05 SI SI201830655T patent/SI3570879T1/sl unknown
- 2018-01-05 WO PCT/IB2018/050084 patent/WO2018134693A1/en not_active Ceased
- 2018-01-05 DK DK18701573.0T patent/DK3570879T3/da active
- 2018-01-05 CN CN201880007697.1A patent/CN110198735A/zh active Pending
- 2018-01-05 MX MX2019008564A patent/MX392525B/es unknown
- 2018-01-05 ES ES18701573T patent/ES2911490T3/es active Active
- 2018-01-05 US US16/478,265 patent/US11413344B2/en active Active
- 2018-01-17 JP JP2018005492A patent/JP7120767B2/ja active Active
-
2019
- 2019-07-18 IL IL268168A patent/IL268168A/en unknown
-
2022
- 2022-07-15 US US17/812,777 patent/US12318438B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11413344B2 (en) | 2022-08-16 |
| CA3050622A1 (en) | 2018-07-26 |
| RU2019122619A3 (es) | 2021-02-20 |
| EP3570879B1 (en) | 2022-03-30 |
| AU2018208844B2 (en) | 2021-02-25 |
| JP7120767B2 (ja) | 2022-08-17 |
| BR112019014833A2 (pt) | 2020-04-14 |
| KR102459629B1 (ko) | 2022-10-28 |
| SI3570879T1 (sl) | 2022-06-30 |
| US12318438B2 (en) | 2025-06-03 |
| HUE059252T2 (hu) | 2022-11-28 |
| KR20190097176A (ko) | 2019-08-20 |
| IL268168A (en) | 2019-09-26 |
| ES2911490T3 (es) | 2022-05-19 |
| JP2018115159A (ja) | 2018-07-26 |
| EP3570879A1 (en) | 2019-11-27 |
| RU2762723C2 (ru) | 2021-12-22 |
| US20190343946A1 (en) | 2019-11-14 |
| MX392525B (es) | 2025-03-12 |
| WO2018134693A1 (en) | 2018-07-26 |
| CN110198735A (zh) | 2019-09-03 |
| US20230190907A1 (en) | 2023-06-22 |
| RU2019122619A (ru) | 2021-02-20 |
| HRP20220573T1 (hr) | 2022-06-10 |
| DK3570879T3 (da) | 2022-04-11 |
| AU2018208844A1 (en) | 2019-07-11 |
| PL3570879T3 (pl) | 2022-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019008564A (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas. | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| MX2021000523A (es) | Composiciones inmunogenicas que comprenden antigenos sacaridos capsulares conjugados y usos de los mismos. | |
| CO2018000503A2 (es) | Composiciones inmunógenas que comprenden antígenos de sacárido capsular conjugados, kits que las comprenden y sus usos | |
| CL2018000319A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| CL2019003264A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas. (divisional solicitud 201703151) | |
| MX2022002106A (es) | Formulaciones de vacuna de vial unico. | |
| MX2025002465A (es) | Metodos y dispositivos para la preparacion de agentes de contraste de ultrasonido | |
| BR112017022755A2 (pt) | formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual | |
| BR112014020025A2 (pt) | vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
| CL2016000787A1 (es) | Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih). | |
| MX2019002552A (es) | Composicion que comprende polisacarido capsular neumococico multivalente-proteina transportadora y uso de la misma. | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| MX2018012270A (es) | Novedosas formulaciones de vacuna neumococica. | |
| MX2023005221A (es) | Composiciones inmunogenicas para uso en vacunas neumococicas. | |
| BR112022002094A2 (pt) | Composição imunogênica | |
| MX388528B (es) | Vacuna que comprende toxoides de clostridium. | |
| AR095501A1 (es) | Vacunas rsv |